Insulet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Insulet 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PODD

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. 

CEO
Ashley A. McEvoy
CEOAshley A. McEvoy
Employees
5,400
Employees5,400
Headquarters
Acton, Massachusetts
HeadquartersActon, Massachusetts
Founded
2000
Founded2000
Employees
5,400
Employees5,400

PODD Key Statistics

Market cap
9.64B
Market cap9.64B
Price-Earnings ratio
39.50
Price-Earnings ratio39.50
Dividend yield
Dividend yield
Average volume
2.08M
Average volume2.08M
High today
$140.03
High today$140.03
Low today
$136.46
Low today$136.46
Open price
$139.00
Open price$139.00
Volume
288.43K
Volume288.43K
52 Week high
$354.88
52 Week high$354.88
52 Week low
$126.40
52 Week low$126.40

Stock Snapshot

The current Insulet(PODD) stock price is $139.20, with a market capitalization of 9.64B. The stock trades at a price-to-earnings (P/E) ratio of 39.50.

On 2026-08-07, Insulet(PODD) stock traded between a low of $136.46 and a high of $140.03. Shares are currently priced at $139.20, which is +2.0% above the low and -0.6% below the high.

The Insulet(PODD)'s current trading volume is 288.43K, compared to an average daily volume of 2.08M.

In the last year, Insulet(PODD) shares hit a 52-week high of $354.88 and a 52-week low of $126.40.

In the last year, Insulet(PODD) shares hit a 52-week high of $354.88 and a 52-week low of $126.40.

PODD News

Simply Wall St 1h
Insulet Is Down 15.9% After Cutting 2026 Revenue Guidance on Type 2 Retention Strains

In early August 2026, Insulet Corporation reported second-quarter 2026 results showing revenue of US$801.7 million and net income of US$95 million, with basic a...

Insulet Is Down 15.9% After Cutting 2026 Revenue Guidance on Type 2 Retention Strains
TipRanks 13h
Insulet price target lowered to $179 from $249 at Canaccord - TipRanks

...

Insulet price target lowered to $179 from $249 at Canaccord - TipRanks
Benzinga 1d
These Analysts Slash Their Forecasts On Insulet After Q2 Results

Insulet Corp. (NASDAQ:PODD) on Wednesday posted upbeat second-quarter results but lowered its full-year revenue guidance. Adjusted earnings rose to $1.66 per s...

These Analysts Slash Their Forecasts On Insulet After Q2 Results

Analyst ratings

61%

of 28 ratings
Buy
60.7%
Hold
39.3%
Sell
0%

More PODD News

TipRanks 1d
Insulet downgraded to Neutral from Buy at BTIG

BTIG analyst Marie Thibault downgraded Insulet (PODD) to Neutral from Buy without a price target The company beat Q2 estimates but called out lower utilization...

Nasdaq 2d
S&P 500 Movers: PODD, CRL

In early trading on Wednesday, shares of Charles River Laboratories International topped the list of the day's best performing components of the S&P 500 index,...

S&P 500 Movers: PODD, CRL
Benzinga 2d
Omnipod Sales Soar, But Insulet's Outlook Cut Sparks Stock Selloff

Adjusted earnings rose to $1.66 per share from $1.17 a year earlier, beating the analyst consensus estimate of $1.45. Revenue increased 23.5% year over year to...

Omnipod Sales Soar, But Insulet's Outlook Cut Sparks Stock Selloff

People also own

Based on the portfolios of people who own PODD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.